Benefits of dasatinib and quercetin treatment in monkeys

In one of the first studies of its kind, the popular senolytic combination, administered systematically for six months, produced several health benefits in these animals. Some effects were enhanced by calorie restriction [1]. Coup de grace for the cells The combination of the drug dasatinib and the flavonoid quercetin, also known as D+Q, is one of the most popular senolytics (compounds that induce death in senescent cells). It has been the subject of several preclinical studies and a few clinical trials, showing a lot of promise [2]. However, there are…

Read More